1.
Unbelievable globally growth of Preimplantation Genetic
Diagnosis Market in 2014 - 2020
Report Description
Since the last two decades, preimplantation genetic diagnosis (PGD)
has been used to detect chromosomal aneuploidy in low prognosis
patients who undergo in-vitro fertilization (IVF). PGD is now being
used to detect a broader range of indications due to advancements in
the medical technology. These indications include chromosomal
aberrations, genetic abnormalities, gender selection, HLA typing, X-

2.
linked diseases and single gene diseases. Demand for PGD is
continuously increasing in patients who undergo IVF in the hope that it
would improve the probability of live birth and reduce the chances of
disabilities and genetic disorders in the offspring.
This report provides in-depth analysis of the preimplantation genetic
diagnosis market and its test types across various regions.
Stakeholders in the report include diagnostic laboratories that provide
PGD services, companies involved in the production of diagnosis kits
and sequencers for PGD, and prospective market players planning to
enter the market. The report comprises executive summary, which
offers a market snapshot that covers the overall information about
various types of tests in the PGD market.
Read Complete Report @ http://www.mrrse.com/preimplantation-
genetic-diagnosis-market
The market overview section explains market dynamics such as
drivers, restraints and opportunities that influence the current and

3.
future status of the preimplantation genetic diagnosis market. Impact
factors such as market attractiveness analysis and regulatory
framework of PGD in various countries has been included in this
section in order to provide a thorough analysis of the overall
competitive scenario of the global preimplantation genetic diagnosis
market. The report covers competitive analysis, which includes heat
map analysis by key market players. Through heat map analysis, the
stakeholder would be able to identify the presence of players across
various segments of the market. All these factors would help market
players gain a thorough understanding of the overall competitive
scenario. The market players can then decide upon the business
strategies and plans to be implemented in order to strengthen their
position in the global market.
The global preimplantation genetic diagnosis market has been
differentiated based on the types of tests and geographies. Based on
the types of tests, the global preimplantation genetic diagnosis market
has been segmented into six categories: PGD for chromosomal
aberrations, aneuploidy screening, X-linked diseases, single gene

4.
disorder, HLA typing and gender selection. A detailed market analysis
of the segments mentioned above has been provided at the global
level in this study. The market analysis is based on market size and
forecast in terms of USD million for the period 2013 to 2020 along with
the compounded annual growth rate (CAGR %) for the period 2014 to
2020, considering 2013 as the base year.
Enquiry For This Report @ http://www.mrrse.com/enquiry/1351
Geographically, the global preimplantation genetic diagnosis market
has been categorized into four regions: North America, Europe, Asia
Pacific and Rest of the World (RoW). This section further provides
market size and forecast for various types of PFD tests in each region.
The market size and forecast of the regional markets is provided for
the period 2012 to 2020. CAGR (%) for each region is also estimated
for the period 2014 to 2020, considering 2013 as the base year. The
report also includes strategic recommendations, which would help
market players sustain and grow in the highly competitive market.

5.
These recommendations would also help new entrants establish a
strong position in the global preimplantation genetic diagnosis market.
Company profiles section comprises key information such as company
overview, financial overview, product portfolio, business strategies and
recent developments about major players operating in the
preimplantation genetic diagnosis market. Key players profiled in the
report include Genesis Genetics, Genea Ltd., Illumina, Inc., Laboratory
Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc.,
Quest Diagnostics, Inc., Reprogenetics LLC and Reproductive
Genetics Institute.
Request a Sample Copy of the Report @
http://www.mrrse.com/sample/1351
The global preimplantation genetic diagnosis market is
segmented into the following categories:

6.
Preimplantation Genetic Diagnosis Market, by Test Type
• PGD for Chromosomal Aberrations
• PGD for Aneuploidy Screening
• PGD for Gender Selection
• PGD for Single Gene Disorder
• PDG for HLA Typing
• PGD for X-linked Diseases
Preimplantation Genetic Diagnosis Market, by Geography
• North America
1. PGD for Chromosomal Aberrations
2. PGD for Aneuploidy Screening
3. PGD for Gender Selection
4. PGD for Single Gene Disorder
5. PDG for HLA Typing
6. PGD for X-linked Diseases

7.
• Europe
1. PGD for Chromosomal Aberration
2. PGD for Aneuploidy Screening
3. PGD for Gender Selection
4. PGD for Single Gene Disorder
5. PDG for HLA Typing
6. PGD for X-linked Diseases
• Asia Pacific
1. PGD for Chromosomal Aberrations
2. PGD for Aneuploidy Screening
3. PGD for Gender Selection
4. PGD for Single Gene Disorder
5. PDG for HLA Typing
6. PGD for X-linked Diseases

8.
• Rest of the World (RoW)
1. PGD for Chromosomal Aberrations
2. PGD for Aneuploidy Screenin
3. PGD for Gender Selection
4. PGD for Single Gene Disorder
5. PDG for HLA Typing
6. PGD for X-linked Diseases
Table of Content
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.4 Research Methodology
1.5 List of Abbreviations

9.
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Preimplantation Genetic Diagnosis
Market
2.2 Comparative Analysis: Global Preimplantation Genetic Diagnosis
Market, by Geography, 2013 & 2020 (Value %)
About MRRSE
MRRSE stands for Market Research Reports Search Engine, the
largest online catalog of latest market research reports based on
industries, companies, and countries. MRRSE sources thousands of
industry reports, market statistics, and company profiles from trusted
entities and makes them available at a click. Besides well-known
private publishers, the reports featured on MRRSE typically come from
national statistics agencies, investment agencies, leading media
houses, trade unions, governments, and embassies.

10.
Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-730-0559
http://www.mrrse.com/
Email: sales@mrrse.com